Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Therapeutic Option for Hepatitis B and C: a French Cohort
- Status
- UNKNOWN
- Phase
- N/A
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- NA
A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.
- Status
- WITHDRAWN
- Phase
- N/A
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of a Smartphone Application to Reduce Adverse Pregnancy Outcomes in Ethiopia
- Status
- COMPLETED
- Phase
- NA
Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050)
- Status
- COMPLETED
- Phase
- PHASE1
Redesigned Process in the Operating Room
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers
- Status
- UNKNOWN
- Phase
- N/A
Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
- Status
- COMPLETED
- Phase
- PHASE2
Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047)
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003)
- Status
- COMPLETED
- Phase
- PHASE1
A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
- Status
- COMPLETED
- Phase
- PHASE2